Product NDC: | 0069-0174 |
Proprietary Name: | Fluorouracil |
Non Proprietary Name: | Fluorouracil |
Active Ingredient(s): | 50 mg/mL & nbsp; Fluorouracil |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0174 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202669 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120718 |
Package NDC: | 0069-0174-01 |
Package Description: | 50 mL in 1 VIAL (0069-0174-01) |
NDC Code | 0069-0174-01 |
Proprietary Name | Fluorouracil |
Package Description | 50 mL in 1 VIAL (0069-0174-01) |
Product NDC | 0069-0174 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluorouracil |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120718 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | FLUOROURACIL |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |